#272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more | David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D. | The Peter Attia Drive - Private Subscriber Feed (🔓 for Vijay Khakhria) | Podwise